CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.94B | -3.98B | 1.02B | 1.78B | 1.64B |
| Total Depreciation and Amortization | 1.15B | 1.13B | 1.17B | 1.15B | 1.15B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 321.00M | 5.21B | 14.00M | 196.00M | -537.00M |
| Change in Net Operating Assets | -1.02B | -1.57B | -309.00M | 1.43B | -394.00M |
| Cash from Operations | 3.39B | 796.00M | 1.90B | 4.56B | 1.86B |
| Capital Expenditure | -784.00M | -698.00M | -607.00M | -743.00M | -768.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.00M | -290.00M | -119.00M | -20.00M | -10.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.21B | -1.10B | -298.00M | 1.00M | 231.00M |
| Cash from Investing | -2.00B | -2.09B | -1.02B | -762.00M | -547.00M |
| Total Debt Issued | 0.00 | 3.05B | 921.00M | -- | 4.27B |
| Total Debt Repaid | -1.27B | -3.72B | 840.00M | -1.60B | -3.07B |
| Issuance of Common Stock | 86.00M | 117.00M | 47.00M | 144.00M | 19.00M |
| Repurchase of Common Stock | -13.00M | -20.00M | -114.00M | -11.00M | -4.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -845.00M | -846.00M | -866.00M | -840.00M | -838.00M |
| Other Financing Activities | 7.00M | 38.00M | -22.00M | -23.00M | 48.00M |
| Cash from Financing | -2.03B | -1.38B | 806.00M | -2.33B | 431.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -640.00M | -2.67B | 1.68B | 1.46B | 1.74B |